BMP-7 inhibits TGF-β-induced invasion of breast cancer cells through inhibition of integrin β3 expression

Cellular Oncology

Volumn 35, Issue 1, 2012, Pages 19-28

  Naber, Hildegonda P H ^a   Wiercinska, Eliza ^a   Pardali, Evangelia ^a   Van Laar, Theo ^a   Nirmala, Ella ^b   Sundqvist, Anders ^d   Van Dam, Hans ^a   Van Der Horst, Geertje ^c   Van Der Pluijm, Gabri ^c   Heckmann, Bertrand ^e   Danen, Erik H J ^b   Dijke, Peter Ten ^a,d  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UPPSALA UNIVERSITY   (Sweden)

^e Galapagos SASU   (France)

Author keywords

BMP 7; Breast cancer; Integrin 3; Invasion; TGF

Indexed keywords

BETA3 INTEGRIN; BONE MORPHOGENETIC PROTEIN 6; OSTEOGENIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN RECEPTOR; ALPHA5 INTEGRIN; CARRIER PROTEIN; GELATINASE A; ITGB3 PROTEIN, HUMAN; NOGGIN PROTEIN; SMAD PROTEIN;

ARTICLE; BREAST METASTASIS; CANCER CELL CULTURE; CELL ASSAY; CELL INVASION; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; SPHEROID CELL; BREAST TUMOR; CANCER INVASION; CELL PROLIFERATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 7; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTEGRIN ALPHA5; INTEGRIN BETA3; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84856776183     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-011-0058-0     Document Type: Article

References (47)

1. G. Poste, I.J. Fidler, The pathogenesis of cancer metastasis. Nature 283, 139-146 (1980) (Pubitemid 10171124)
2. J.D. Hood, D.A. Cheresh, Role of integrins in cell invasion and migration. Nat. Rev. Canc. 2, 91-100 (2002) (Pubitemid 37328796)
3. W. Guo, F.G. Giancotti, Integrin signalling during tumour progression. Nat. Rev. Mol. Cell. Biol. 5, 816-826 (2004) (Pubitemid 39336275)
4. H. Liapis, A. Flath, S. Kitazawa, Integrin αvβ3 expression by bone-residing breast cancer metastases. Diagn. Mol. Pathol. 5, 127-135 (1996)
5. I. Pecheur, O. Peyruchaud, C.M. Serre, J. Guglielmi, C. Voland, F. Bourre, C. Margue, M. Cohen-Solal, A. Buffet, N. Kieffer, P. Clezardin, Integrin αvβ3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J. 16, 1266-1268 (2002)
6. E.K. Sloan, N. Pouliot, K.L. Stanley, J. Chia, J.M. Moseley, D.K. Hards, R.L. Anderson, Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Canc. Res. 8, R20 (2006)
7. Y. Zhao, R. Bachelier, I. Treilleux, P. Pujuguet, O. Peyruchaud, R. Baron, P. Clement-Lacroix, P. Clezardin, Tumor αvβ3 integrin is a therapeutic target for breast cancer bone metastases. Canc. Res. 67, 5821-5830 (2007) (Pubitemid 46985016)
8. J. Massagué, TGF-β in cancer. Cell 134, 215-230 (2008)
9. R.J. Akhurst, R. Derynck, TGF-β signaling in cancer-a doubleedged sword. Trends Cell Biol. 11, S44-S51 (2001)
10. S. Desruisseau, J. Palmari, C. Giusti, S. Romain, P.M. Martin, Y. Berthois, Determination of TGF-β1 protein level in human primary breast cancers and its relationship with survival. Br. J. Canc. 94, 239-246 (2006) (Pubitemid 43151542)
11. A. Ghellal, C. Li, M. Hayes, G. Byrne, N. Bundred, S. Kumar, Prognostic significance of TGF-β1 and TGF-β3 in human breast carcinoma. Anticancer. Res. 20, 4413-4418 (2000) (Pubitemid 32141796)
12. S.M. Sheen-Chen, H.S. Chen, C.W. Sheen, H.L. Eng, W.J. Chen, Serum levels of transforming growth factor-β1 in patients with breast cancer. Arch. Surg. 136, 937-940 (2001)
13. M. Deckers, M. van Dinther, J. Buijs, I. Que, C. Lowik, G. van der Pluijm, P. ten Dijke, The tumor suppressor Smad4 is required for transforming growth factor-β-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Canc. Res. 66, 2202-2209 (2006)
14. Y. Kang, W. He, S. Tulley, G.P. Gupta, I. Serganova, C.R. Chen, K. Manova-Todorova, R. Blasberg, W.L. Gerald, J. Massagué, Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U.S.A. 102, 13909-13914 (2005) (Pubitemid 41377677)
15. J.J. Yin, K. Selander, J.M. Chirgwin, M. Dallas, B.G. Grubbs, R. Wieser, J. Massagué, G.R. Mundy, T.A. Guise, TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Investig. 103, 197-206 (1999) (Pubitemid 29053137)
16. M. Petersen, E. Pardali, G. van der Horst, H. Cheung, C. van den Hoogen, G. van der Pluijm, P. ten Dijke, Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene 29, 1351-1361 (2010)
17. J.L. Wrana, Crossing Smads. Sci. STKE 2000, re1 (2000)
18. P. ten Dijke, C.S. Hill, New insights into TGF-β-Smad signalling. Trends Biochem. Sci. 29, 265-273 (2004)
19. P. ten Dijke, O. Korchynskyi, G. Valdimarsdottir, M.J. Goumans, Controlling cell fate by bone morphogenetic protein receptors. Mol. Cell. Endocrinol. 211, 105-113 (2003) (Pubitemid 37491242)
20. A. Moustakas, C.H. Heldin, Non-Smad TGF-β signals. J. Cell Sci. 118, 3573-3584 (2005)
21. J. Xu, S. Lamouille, R. Derynck, TGF-β-induced epithelial to mesenchymal transition. Cell Res. 19, 156-172 (2009)
22. M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, F. Strutz, R. Kalluri, BMP-7 counteracts TGF-β1-induced epithelialto-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968 (2003) (Pubitemid 36889942)
23. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, I. Que, R. Schwaninger, C. Rentsch, P. ten Dijke, A.M. Cleton-Jansen, K. Driouch, R. Lidereau, R. Bachelier, S. Vukicevic, P. Clezardin, S. E. Papapoulos,M.G. Cecchini, C.W. Lowik, G. van der Pluijm, Bone morphogenetic protein-7 in the development and treatment of bone metastases from breast cancer. Canc. Res. 67, 8742-8751 (2007) (Pubitemid 47437450)
24. J.T. Buijs, C.A. Rentsch, G. van der Horst, P.G. van Overveld, A. Wetterwald, R. Schwaninger, N.V. Henriquez, P. ten Dijke, F. Borovecki, R. Markwalder, G.N. Thalmann, S.E. Papapoulos, R. C. Pelger, S. Vukicevic, M.G. Cecchini, C.W. Lowik, G. van der Pluijm, BMP-7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivo. Am. J. Pathol. 171, 1047-1057 (2007) (Pubitemid 47441001)
25. E. Wiercinska, H.P.H. Naber, E. Pardali, G. van der Pluijm, H. van Dam, P. ten Dijke, The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Canc. Res. Treat. 128(3), 657-666 (2010)
26. J.T. Buijs, N.V. Henriquez, P.G. van Overveld, G. van der Horst, P. ten Dijke, G. van der Pluijm, TGF-β and BMP-7 interactions in tumour progression and bone metastasis. Clin. Exp. Metastasis 24, 609-617 (2007) (Pubitemid 50003597)
27. H.D. Soule, T.M. Maloney, S.R. Wolman, W.D. Peterson Jr., R. Brenz, C.M. McGrath, J. Russo, R.J. Pauley, R.F. Jones, S.C. Brooks, Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Canc. Res. 50, 6075-6086 (1990) (Pubitemid 20331424)
28. L.B. Strickland, P.J. Dawson, S.J. Santner, F.R. Miller, Progression of premalignant MCF10AT generates heterogeneous malignant variants with characteristic histologic types and immunohistochemical markers. Breast Canc. Res. Treat. 64, 235-240 (2000) (Pubitemid 32055831)
29. S.J. Santner, P.J. Dawson, L. Tait, H.D. Soule, J. Eliason, A.N. Mohamed, S.R. Wolman, G.H. Heppner, F.R. Miller, Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Canc. Res. Treat. 65, 101-110 (2001) (Pubitemid 32193613)
30. U. Persson, S. Souchelnytskyi, P. Franzen, K. Miyazono, P. ten Dijke, C.H. Heldin, Transforming growth factor (TGF-β)-specific signaling by chimeric TGF-β type II receptor with intracellular domain of activin type IIB receptor. J. Biol. Chem. 272, 21187-21194 (1997) (Pubitemid 27373980)
31. S. Dennler, S. Itoh, D. Vivien, P. ten Dijke, S. Huet, J.M. Gauthier, Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17, 3091-3100 (1998) (Pubitemid 28254381)
32. O. Korchynskyi, P. ten Dijke, Identification and functional characterization of distinct critically important bone morphogenetic protein-specific response elements in the Id1 promoter. J. Biol. Chem. 277, 4883-4891 (2002) (Pubitemid 34968524)
33. H. Zhao, H. Kitaura, M.S. Sands, F.P. Ross, S.L. Teitelbaum, D.V. Novack, Critical role of β3 integrin in experimental postmenopausal osteoporosis. J. Bone Miner. Res. 20, 2116-2123 (2005) (Pubitemid 41698775)
34. M. Oft, J. Peli, C. Rudaz, H. Schwarz, H. Beug, E. Reichmann, TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Gene. Dev. 10, 2462-2477 (1996) (Pubitemid 26341881)
35. R. Fuchshofer, A.H. Yu, U. Welge-Lussen, E.R. Tamm, Bone morphogenetic protein-7 is an antagonist of transforming growth factor-β2 in human trabecular meshwork cells. Investig. Ophthalmol. Vis. Sci. 48, 715-726 (2007) (Pubitemid 351260705)
36. D.D. Luo, A. Phillips, D. Fraser, Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression. Am. J. Pathol. 176, 1139-1147 (2010)
37. I. Notting, J. Buijs, R. Mintardjo, G. van der Horst, S. Vukicevic, C. Lowik, N. Schalij-Delfos, J. Keunen, G. van der Pluijm, Bone morphogenetic protein-7 inhibits tumor growth of human uveal melanoma in vivo. Investig. Ophthalmol. Vis. Sci. 48, 4882-4889 (2007) (Pubitemid 351260892)
38. A.J. Galliher, W.P. Schiemann, β3 integrin and Src facilitate transforming growth factor-β mediated induction of epithelialmesenchymal transition in mammary epithelial cells. Breast Canc. Res. 8, R42 (2006)
39. D.V. Pechkovsky, A.K. Scaffidi, T.L. Hackett, J. Ballard, F. Shaheen, P.J. Thompson, V.J. Thannickal, D.A. Knight, Transforming growth factor β1 induces αvβ3 integrin expression in human lung fibroblasts via a β3 integrin-, c-Src-, and p38 MAPK-dependent pathway. J. Biol. Chem. 283, 12898-12908 (2008)
40. T. Ebisawa, K. Tada, I. Kitajima, K. Tojo, T.K. Sampath,M. Kawabata, K. Miyazono, T. Imamura, Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation. J. Cell Sci. 112(Pt 20), 3519-3527 (1999)
41. B.L. Rosenzweig, T. Imamura, T. Okadome, G.N. Cox, H. Yamashita, P. ten Dijke, C.H. Heldin, K. Miyazono, Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. U. S. A. 92, 7632-7636 (1995)
42. P. ten Dijke, H. Yamashita, T.K. Sampath, A.H. Reddi, M. Estevez, D.L. Riddle, H. Ichijo, C.H. Heldin, K. Miyazono, Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269, 16985-16988 (1994) (Pubitemid 24204009)
43. H. Yamashita, P. ten Dijke, D. Huylebroeck, T.K. Sampath, M. Andries, J.C. Smith, C.H. Heldin, K. Miyazono, Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130, 217-226 (1995)
44. M.S. Friedman, M.W. Long, K.D. Hankenson, Osteogenic differentiation of human mesenchymal stem cells is regulated by bone morphogenetic protein-6. J. Cell. Biochem. 98, 538-554 (2006) (Pubitemid 43727174)
45. K. Song, C. Krause, S. Shi, M. Patterson, R. Suto, L. Grgurevic, S. Vukicevic,M. van Dinther, D. Falb, P. ten Dijke,M.H. Alaoui-Ismaili, Identification of a key residue mediating bone morphogenetic protein (BMP)-6 resistance to noggin inhibition allows for engineered BMPs with superior agonist activity. J. Biol. Chem. 285, 12169-12180 (2010)
46. B. Tang, M. Vu, T. Booker, S.J. Santner, F.R. Miller, M.R. Anver, L.M. Wakefield, TGF-β switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Investig. 112, 1116-1124 (2003) (Pubitemid 38056326)
47. M. Kadota, H.H. Yang, B. Gomez, M. Sato, R.J. Clifford, D. Meerzaman, B.K. Dunn, L.M. Wakefield, M.P. Lee, Delineating genetic alterations for tumor progression in the MCF10A series of breast cancer cell lines. PLoS One 5, e9201 (2010)